Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-07-17Clinical Trial Update: Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension [Phase 3]
Phase 3 trial update for TRC150094 evaluating safety and efficacy to reduce cardiovascular risk in adults with diabetes, dyslipidemia, and h…
-
FDA approval · 2020-07-16FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (GSMS, Incorporated)
The FDA approved a supplemental application for a lisinopril and hydrochlorothiazide fixed-dose combination from GSMS, Incorporated.
-
FDA approval · 2020-07-16FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Lisinopril and Hydrochlorothiazide from Aurobindo Pharma Limited, a generic combination used…
-
FDA approval · 2020-07-10FDA Approved: VALSARTAN — Supplemental Application (Solco Healthcare US, LLC)
FDA approved a supplemental application for VALSARTAN by Solco Healthcare US, LLC.
-
FDA approval · 2020-07-09FDA Approved: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE — Original Application (Edenbridge Pharmaceuticals LLC.)
FDA approved a generic bisoprolol fumarate and hydrochlorothiazide tablet under an original ANDA from Edenbridge Pharmaceuticals LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-07-07FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for the generic fixed-dose combination of lisinopril and hydrochlorothiazide from Actavis Pharma, In…
-
FDA approval · 2020-07-06FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Eugia US LLC)
FDA approves Verapamil hydrochloride as an original application generic; the product is used to treat hypertension, angina, and certain arrh…
-
FDA approval · 2020-07-01FDA Approved: FUROSEMIDE — Original Application (Gland Pharma Limited)
FDA approves the original generic application for furosemide from Gland Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2020-06-30Clinical Trial Update: Coronavirus (COVID-19) ACEi/ARB Investigation [Phase 4]
Phase 4 clinical trial investigating ACE inhibitors and ARBs in hypertension and COVID-19 has been suspended.
-
CLINICAL_TRIALS trial_result · 2020-06-26Clinical Trial Update: A Study of LY2623091 in Participants With High Blood Pressure [Phase 2]
Phase 2 clinical trial update for LY2623091 in participants with high blood pressure (primary hypertension) has completed with posted result…
-
CLINICAL_TRIALS trial_result · 2020-06-24Clinical Trial Update: Blood Pressure in Blacks and Calcium (BBC) and Vitamin D Study [Phase 2]
Phase 2 clinical trial investigating blood pressure in Black individuals with hypertension and vitamin D deficiency; study completed with po…
-
FDA approval · 2020-06-17FDA Approved: ALISKIREN — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application from Prasco Laboratories for aliskiren hemifumarate (aliskiren), enabling the marketing of a generic…
-
EMA guidance · 2020-06-09Latest data support continued use of ACE inhibitors and ARB medicines during COVID-19 pandemic
EU regulators indicate continued use of ACE inhibitors and ARB medicines is supported by latest data during the COVID-19 pandemic.
-
FDA approval · 2020-06-02FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Solco Healthcare US, LLC)
FDA approved a supplemental application for a generic fixed-dose combination of irbesartan and hydrochlorothiazide for hypertension, manufac…
-
FDA approval · 2020-05-31FDA Approved: FUROSEMIDE — Supplemental Application (Solco Healthcare LLC)
FDA approves a supplemental ANDA for furosemide from Solco Healthcare LLC.
-
FDA approval · 2020-05-28FDA Approved: FUROSEMIDE — Supplemental Application (Ipca Laboratories Limited)
The FDA approved Ipca Laboratories Limited's supplemental application for furosemide under an ANDA, updating the approved product.
-
CLINICAL_TRIALS trial_result · 2020-05-28Clinical Trial Update: Pressure Assessment to Improve Outcomes After TAVR: a Registry [EARLY_Phase 1]
Early-phase registry trial assessing pressure measurement after TAVR to improve outcomes has completed with posted results.
-
FDA approval · 2020-05-27FDA Approved: CLONIDINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for clonidine hydrochloride from Actavis Pharma, Inc. to bring a generic version of the antihype…
-
CLINICAL_TRIALS trial_result · 2020-05-27Clinical Trial Update: Effect of a Higher Blood-pressure on Right Ventricular Function [Phase 4]
Phase 4 clinical trial update examining the effect of higher blood pressure on right ventricular function has completed.
-
FDA approval · 2020-05-21FDA Approved: CLONIDINE HYDROCHLORIDE — Supplemental Application (Somerset Therapeutics, LLC)
FDA approved a supplemental application for clonidine hydrochloride from Somerset Therapeutics, LLC, under an ANDA, indicating approval of a…
-
FDA approval · 2020-05-21FDA Approved: GUANFACINE — Supplemental Application (Actavis Pharma, Inc.)
The FDA granted approval of a supplemental application for guanfacine from Actavis Pharma, enabling the generic version to be marketed. This…
-
FDA approval · 2020-05-21FDA Approved: GUANFACINE — Supplemental Application (Sun Pharmaceutical Industries, Inc)
FDA approved a supplemental application for guanfacine from Sun Pharmaceutical Industries (ANDA205689).
-
FDA approval · 2020-05-21FDA Approved: CLONIDINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for clonidine hydrochloride by Lupin Pharmaceuticals, Inc., under the ANDA framework.
-
FDA label_change · 2020-05-19FDA Approved: CAPTOPRIL — Supplemental Application (Solco Healthcare US, LLC)
The FDA approved a supplemental application for captopril submitted by Solco Healthcare US, LLC, updating the labeling for the generic drug …
-
FDA approval · 2020-05-18FDA Approved: OLMESARTAN MEDOXOMIL — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original application for olmesartan medoxomil tablets (generic olmesartan medoxomil) from Rising Pharma Holdings, Inc., for…